In this report, we cover catalysts from 36 drugs, devices and diagnostics expected to occur in early 2017. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. The results of the catalysts highlighted in our Q4 2016 Outlook Report can be found on Page 5. At the end of this report, we have included a list of Large Impact catalysts in the drug and device/diagnostic areas through early 2017.

For the full report, please download the PDF version at the top of this page. Additionally, the catalyst calendars are provided in Excel by downloading the supplemental material above.

Like our report? Have any questions or feedback? Please let us know at askanalyst@sagientresearch.com.

For our disclosures, please read the Biomedtracker Research Standards.